Takeda Pharmaceutical Company Limited Logo

Takeda Pharmaceutical Company Limited

R&D-driven biopharma creating medicines for Oncology, Rare Diseases, GI, and Neuroscience.

4502 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区道修町四丁目1番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Takeda Pharmaceutical Company Limited is a global, R&D-driven biopharmaceutical leader dedicated to discovering and delivering life-transforming treatments. With a history spanning over 240 years, the company translates science into highly innovative medicines. Its core business activities include the research, development, manufacturing, and commercialization of pharmaceutical drugs. Takeda focuses its efforts on four core therapeutic areas: Oncology, Rare Diseases, Gastroenterology, and Neuroscience, with additional targeted investments in Plasma-Derived Therapies and Vaccines. The company is committed to a patient-centered approach, aiming to create better health and a brighter future for people worldwide through its diverse and balanced portfolio.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-01 05:11
Registration Form
訂正発行登録書
Japanese 11.9 KB
2025-07-01 05:11
Registration Form
訂正発行登録書
Japanese 11.3 KB
2025-07-01 05:11
Post-Annual General Meeting Information
臨時報告書
Japanese 28.6 KB
2025-06-25 09:33
Registration Form
確認書
Japanese 9.4 KB
2025-06-25 09:32
Governance Information
内部統制報告書-第148期(2024/04/01-2025/03/31)
Japanese 26.8 KB
2025-06-25 09:31
Annual Report
有価証券報告書-第148期(2024/04/01-2025/03/31)
Japanese 3.6 MB
2025-06-12 04:51
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2025-06-10 08:31
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 65.6 KB
2025-06-06 03:43
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 129.2 KB
2025-06-02 08:34
Registration Form
発行登録書(株券、社債券等)
Japanese 50.3 KB
2025-05-14 05:06
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 31.7 KB
2025-04-14 04:57
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.5 KB
2025-04-14 04:57
Registration Form
発行登録書(株券、社債券等)
Japanese 37.1 KB
2025-03-13 03:57
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.9 KB
2025-02-13 03:51
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.1 KB

Automate Your Workflow. Get a real-time feed of all Takeda Pharmaceutical Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Takeda Pharmaceutical Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP

Talk to a Data Expert

Have a question? We'll get back to you promptly.